Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of combination gefitinib and methotrexate to treat ectopic pregnancies (GEM II) : study protocol

Horne, Andrew W.Skubisz, Monika MDoust, AnnDuncan, W Colin DuncanWallace, EuanCritchley, Hilary O DJohns, Terence GNorman, Jane EBhattacharya, SiladityaMollison, JillRassmusen, MichaelTong, Stephen2013-11-262013-11-262013-07-18Horne, A W, Skubisz, M M, Doust, A, Duncan, W C D, Wallace, E, Critchley, H O D, Johns, T G, Norman, J E, Bhattacharya, S, Mollison, J, Rassmusen, M & Tong, S 2013, 'Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of combination gefitinib and methotrexate to treat ectopic pregnancies (GEM II) : study protocol', BMJ Open, vol. 3, no. 7, e002902. https://doi.org/10.1136/bmjopen-2013-0029022044-6055ORCID: /0000-0002-4588-356X/work/159509551http://hdl.handle.net/2164/3005257176engSDG 3 - Good Health and Well-beingR MedicineRPhase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of combination gefitinib and methotrexate to treat ectopic pregnancies (GEM II) : study protocolJournal article10.1136/bmjopen-2013-00290237